uCT 780
Shanghai United Imaging Healthcare Co., Ltd. • Radiology • 01/07/2025
Device Purpose
The uCT 780 Computed Tomography X-Ray System, enhanced with AI-based Deep Recon (DELTA) and uWS-CT-Dual Energy Analysis software, is designed to generate high-quality cross-sectional images across various body regions. This system's core methodology involves advanced image reconstruction and dual-energy processing, demonstrated to achieve equivalent or superior diagnostic image quality at potentially lower radiation doses, particularly for applications like low-dose CT lung cancer screening.
Summary
The Shanghai United Imaging Healthcare Co., Ltd. uCT 780 Computed Tomography X-Ray System, including its uWS-CT-Dual Energy Analysis software, is designed for producing cross-sectional images of various body parts such as the head, neck, cardiac, and vascular regions. A key application is low-dose CT lung cancer screening, aiding in early nodule detection. The integrated Dual Energy Analysis software further enhances diagnostic capabilities by processing images acquired at different energy spectra to provide insights into the chemical composition of scanned tissues. Recent modifications to the system's AI-based Deep Recon (DELTA) feature have undergone rigorous performance testing, demonstrating significant improvements. Bench tests using phantoms revealed enhanced image quality metrics, including reduced noise, improved low contrast detectability, and better spatial resolution, suggesting the potential for diagnostic imaging at lower radiation doses. Clinical evaluations, supported by a radiologist reader study, confirmed that the modified system delivers image quality equivalent to or superior to a predicate device. Users are advised to collaborate with radiologists and physicists to establish appropriate dose protocols, especially when utilizing the DELTA feature or for pediatric patients, to ensure optimal diagnostic image quality.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What specific algorithms or methodologies does the AI-based Deep Recon (DELTA) feature employ to achieve image quality improvements at reduced radiation doses?; Could the document provide a detailed breakdown of the quantitative improvements in noise, low contrast detectability, and spatial resolution observed in bench tests, along with the corresponding radiation dose reductions?; What were the specific clinical scenarios or anatomical regions evaluated in the reader study, and were there any areas where the modified system did not show superiority over the predicate device?; How does the uWS-CT-Dual Energy Analysis software's ability to reveal 'chemical composition' translate into specific clinical benefits or diagnostic applications beyond general imaging?; What are the precise recommendations or dose optimization strategies advised for pediatric populations or when using the DELTA feature to ensure diagnostic image quality while minimizing dose?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly